AORT

SEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · nonDerivative · entry 2

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,842

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025.

SEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025.

SEC source: 0001628280-25-052266 · wk-form4_1763140209.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,842

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-052262 · wk-form4_1763140100.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,408

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-052297 · wk-form4_1763148515.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,380

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-052264 · wk-form4_1763140154.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,993

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-052260 · wk-form4_1763140046.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,641

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-051798 · wk-form4_1762996328.xml · derivative · entry 4

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2029-11-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

SEC source: 0001628280-25-051798 · wk-form4_1762996328.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,169

SEC source: 0001628280-25-051798 · wk-form4_1762996328.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-051798 · wk-form4_1762996328.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,169

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction

SEC source: 0001628280-25-051795 · wk-form4_1762996112.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 835,203

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-051793 · wk-form4_1762996064.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,405

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-051791 · wk-form4_1762996005.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,862

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-25-051789 · wk-form4_1762995941.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,634

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001849615-25-000003 · wk-form4_1756418919.xml · derivative · entry 3

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,200 shares

Expires 2029-11-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

SEC source: 0001849615-25-000003 · wk-form4_1756418919.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,200

F1 · price: Reflects weighted average price. Range of prices were between $43.84 to $44.26. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001849615-25-000003 · wk-form4_1756418919.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001540065-25-000005 · wk-form4_1756219178.xml · derivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2029-11-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

SEC source: 0001540065-25-000005 · wk-form4_1756219178.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,129

SEC source: 0001540065-25-000005 · wk-form4_1756219178.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,129

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001408470-25-000003 · wk-form4_1755617286.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 852,783

F1 · price: Reflects weighted average price. Range of prices were between $42.25 to $42.585. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001540065-25-000003 · wk-form4_1755179918.xml · derivative · entry 4

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,975 shares

Expires 2027-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 19, 2021.

SEC source: 0001540065-25-000003 · wk-form4_1755179918.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,129

F2 · price: Reflects weighted average price. Range of prices were between $42.12 to $43.62. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001540065-25-000003 · wk-form4_1755179918.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,510

F1 · price: Reflects weighted average price. Range of prices were between $42.14 to $43.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001540065-25-000003 · wk-form4_1755179918.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001653206-25-000003 · wk-form4_1755179807.xml · derivative · entry 3

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,802 shares

Expires 2027-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 19, 2021.

SEC source: 0001653206-25-000003 · wk-form4_1755179807.xml · nonDerivative · entry 2

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,778

F1 · price: Reflects weighted average price. Range of prices were between $43.470 to $43.835. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001653206-25-000003 · wk-form4_1755179807.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,580

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-039607 · wk-form4_1754944628.xml · derivative · entry 3

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Commn Stock · 7,992 shares

Expires 2026-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.

SEC source: 0001628280-25-039607 · wk-form4_1754944628.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,651

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

SEC source: 0001628280-25-039607 · wk-form4_1754944628.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,643

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

SEC source: 0001628280-26-003820 · wk-form5_1769633226.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,722

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

SEC source: 0001628280-26-003824 · wk-form5_1769633614.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,287

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

SEC source: 0001628280-26-003822 · wk-form5_1769633452.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,716

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

SEC source: 0000784199-25-000133 · wk-form4_1750261700.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,200

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

F2 · price: Reflects the price the shares were sold.

SEC source: 0000784199-25-000133 · wk-form4_1750261700.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,436

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

F2 · price: Reflects the price the shares were sold.

SEC source: 0000784199-25-000131 · wk-form4_1750119734.xml · nonDerivative · entry 4

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,200

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

F3 · price: Reflects weighted average price for Employee Stock Purchase Plan. Range of prices were between $28.18 to $28.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000784199-25-000131 · wk-form4_1750119734.xml · nonDerivative · entry 3

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,026

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

F4 · price: Reflects weighted average price for Performance Stock Units. Range of prices were between $28.17 to $28.675. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000784199-25-000131 · wk-form4_1750119734.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,332

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

F3 · price: Reflects weighted average price for Employee Stock Purchase Plan. Range of prices were between $28.18 to $28.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000784199-25-000131 · wk-form4_1750119734.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,585

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

F2 · price: Reflects weighted average price for Performance Stock Units. Range of prices were between $28.175 to $28.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000784199-25-000121 · wk-form4_1748381368.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,510

F1 · price: Reflects the price the shares were sold.

SEC source: 0000784199-25-000119 · wk-form4a_1748377571.xml · nonDerivative · entry 1

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,384

F1 · price: Reflects the price the shares were sold.

F2 · balance_after: Mr. Semedo also indirectly owns 600 shares through his spouse.

F3 · balance_after: As a result of an administrative error, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

SEC source: 0000784199-25-000092 · wk-form4_1748360324.xml · nonDerivative · entry 1

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,059

F1 · price: Reflects the price the shares were sold.

F2 · balance_after: Mr. Semedo also indirectly owns 600 shares through his spouse.

SEC source: 0000784199-25-000117 · wk-form4_1748377397.xml · nonDerivative · entry 1

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,984

F1 · shares: RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan.

F2 · balance_after: Mr. Semedo also indirectly owns 600 shares through his spouse.

SEC source: 0000784199-25-000115 · wk-form4_1748377189.xml · nonDerivative · entry 1

Borgstrom Marna P · CIK 0001744267 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,088

F1 · shares: RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0000784199-25-000113 · wk-form4_1748377100.xml · nonDerivative · entry 1

BEVEVINO DANIEL J · CIK 0001186458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,061

F1 · shares: RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0000784199-25-000111 · wk-form4_1748377016.xml · nonDerivative · entry 1

ACKERMAN THOMAS F · CIK 0001141720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,896

F1 · shares: RSA Grant vests on May 22 2026, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0000784199-25-000109 · wk-form4_1748376921.xml · nonDerivative · entry 1

Salveson Jon W · CIK 0001372026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,840

F1 · shares: RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0000784199-25-000107 · wk-form4_1748376777.xml · nonDerivative · entry 1

Hoff Elizabeth A · CIK 0001949762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,389

F1 · shares: RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan.